Douglas Sawyer
-
Heart failure therapy shows promise in early clinical trial
Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco. Read MoreMar 14, 2013
-
VHVI reaches milestone in heart valve procedures
Vanderbilt Heart and Vascular Institute recently performed its 100th transcatheter aortic heart valve-replacement (TAVR) on 91-year-old Murline Westover from Lavinia, Tenn. Read MoreAug 2, 2012
-
My Health Chat: Innovation in Heart Care and Genomic Medicine
Have you ever wanted to ask the world’s leading physicians and medical researchers about their work and how it affects you? My Health Chat is your chance. Join Vanderbilt University Medical Center’s Dr. Jim Jirjis, as he discusses the latest advancements in genomic medicine and heart care innovations with Dr. Read MoreNov 14, 2011
-
VUMC to launch live video chat series Nov. 9
Jim Jirjis (Vanderbilt University) Patients, caregivers and consumers will have a chance Nov. 9 to ask questions about the latest in genomic medicine and heart care innovations during a live online video chat with Vanderbilt University Medical Center experts. The free event, which will be from 1:30… Read MoreOct 28, 2011
-
Promise of Discovery campaign adds video chat, new story lines
Dr. Emily Kurtz (left) of the Vanderbilt Heart and Vascular Institute appears in new ads for the Promise of Discovery campaign. (Vanderbilt University) Vanderbilt University Medical Center’s award-winning “Promise of Discovery” initiative continues with the creation of additional story lines and the launch of a new series… Read MoreOct 21, 2011
-
NIH grant bolsters emergency medicine training
The Department of Emergency Medicine has received a $3.5 million training grant from the National Institutes of Health, one of the nation’s first training grants in emergency medicine. Read MoreJun 21, 2011